LIFE HEALTHCARE GROUP HOLDINGS LIMITED Financials Life Healthcare Group Holdings Limited
Equities
LHC
ZAE000145892
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.36 ZAR | +1.37% |
|
+3.39% | -43.60% |
| Apr. 22 | Ninety One SA Ltd. acquired unknown minority stake in Life Healthcare Group Holdings Limited. | CI |
| Apr. 11 | Life Healthcare Group Holdings Limited Announces Executive Changes | CI |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 33,012 | 24,814 | 33,131 | 25,086 | 29,250 | 14,920 | - | - |
| Enterprise Value (EV) 1 | 44,330 | 38,930 | 43,509 | 35,969 | 29,250 | 19,424 | 19,321 | 19,164 |
| P/E ratio | 12.9 x | -267 x | 18.9 x | 16.3 x | 111 x | 9.82 x | 7.82 x | 6.77 x |
| Yield | 4.1% | - | 1.1% | 2.32% | 2.17% | 5.13% | 6.69% | 7.76% |
| Capitalization / Revenue | 1.29 x | 0.98 x | 1.23 x | 0.89 x | 1.29 x | 0.62 x | 0.58 x | 0.55 x |
| EV / Revenue | 1.73 x | 1.53 x | 1.62 x | 1.28 x | 1.29 x | 0.8 x | 0.75 x | 0.7 x |
| EV / EBITDA | 7.74 x | 8.96 x | 8.61 x | 7.14 x | 8.14 x | 4.95 x | 4.4 x | 3.99 x |
| EV / FCF | 17.1 x | 18.7 x | 13.4 x | 19.1 x | 9.29 x | 11.1 x | 12.2 x | 8.66 x |
| FCF Yield | 5.85% | 5.34% | 7.45% | 5.24% | 10.8% | 8.97% | 8.22% | 11.6% |
| Price to Book | 2.04 x | 1.46 x | 1.83 x | 1.33 x | 1.44 x | 1 x | 0.94 x | 0.88 x |
| Nbr of stocks (in thousands) | 1,455,567 | 1,454,493 | 1,453,736 | 1,454,244 | 1,443,731 | 1,440,182 | - | - |
| Reference price 2 | 22.68 | 17.06 | 22.79 | 17.25 | 20.26 | 10.36 | 10.36 | 10.36 |
| Announcement Date | 11/21/19 | 11/19/20 | 11/18/21 | 11/17/22 | 11/16/23 | - | - | - |
1ZAR in Million2ZAR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 25,672 | 25,386 | 26,885 | 28,206 | 22,641 | 24,251 | 25,883 | 27,234 |
| EBITDA 1 | 5,727 | 4,346 | 5,051 | 5,039 | 3,594 | 3,922 | 4,386 | 4,804 |
| EBIT 1 | 3,905 | 2,108 | 2,980 | 2,701 | - | 2,787 | 3,199 | 3,553 |
| Operating Margin | 15.21% | 8.3% | 11.08% | 9.58% | - | 11.49% | 12.36% | 13.05% |
| Earnings before Tax (EBT) 1 | 3,706 | 581 | 2,409 | 2,482 | 1,911 | 2,515 | 2,810 | 3,067 |
| Net income 1 | 2,569 | -93 | 1,754 | 1,531 | 264 | 1,671 | 1,812 | 2,064 |
| Net margin | 10.01% | -0.37% | 6.52% | 5.43% | 1.17% | 6.89% | 7% | 7.58% |
| EPS 2 | 1.758 | -0.0640 | 1.206 | 1.058 | 0.1830 | 1.055 | 1.324 | 1.531 |
| Free Cash Flow 1 | 2,595 | 2,077 | 3,243 | 1,884 | 3,147 | 1,742 | 1,589 | 2,214 |
| FCF margin | 10.11% | 8.18% | 12.06% | 6.68% | 13.9% | 7.18% | 6.14% | 8.13% |
| FCF Conversion (EBITDA) | 45.31% | 47.79% | 64.21% | 37.39% | 87.56% | 44.42% | 36.22% | 46.08% |
| FCF Conversion (Net income) | 101.01% | - | 184.89% | 123.06% | 1,192.05% | 104.27% | 87.69% | 107.28% |
| Dividend per Share 2 | 0.9300 | - | 0.2500 | 0.4000 | 0.4400 | 0.5317 | 0.6928 | 0.8040 |
| Announcement Date | 11/21/19 | 11/19/20 | 11/18/21 | 11/17/22 | 11/16/23 | - | - | - |
1ZAR in Million2ZAR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 13,273 | 13,244 | 12,142 | 13,004 | 13,881 | 13,544 | 14,662 | 15,290 | 7,351 | 11,449 | 12,380 |
| EBITDA | - | 2,923 | - | 2,418 | 2,633 | - | - | 2,690 | - | - | - |
| EBIT | - | 1,847 | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | 13.95% | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | 1.514 | 0.5350 | -0.5990 | - | 0.6710 | 0.4120 | 0.6460 | 0.3790 | -0.1960 | 0.3600 | 0.5300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/21/19 | 5/11/20 | 11/19/20 | 5/27/21 | 11/18/21 | 5/26/22 | 11/17/22 | 5/24/23 | 11/16/23 | - | - |
1ZAR in Million2ZAR
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 11,318 | 14,116 | 10,378 | 10,883 | - | 4,504 | 4,401 | 4,244 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.976 x | 3.248 x | 2.055 x | 2.16 x | - | 1.149 x | 1.003 x | 0.8836 x |
| Free Cash Flow 1 | 2,595 | 2,077 | 3,243 | 1,884 | 3,147 | 1,742 | 1,589 | 2,214 |
| ROE (net income / shareholders' equity) | 16.5% | 5.34% | 9.34% | 8.32% | 5.42% | 9.74% | 13% | 14.4% |
| ROA (Net income/ Total Assets) | 4.42% | 2.21% | 3.93% | 3.69% | 2.4% | 5.77% | 7.34% | 8% |
| Assets 1 | 58,130 | -4,203 | 44,645 | 41,513 | 10,982 | 28,980 | 24,680 | 25,794 |
| Book Value Per Share 2 | 11.10 | 11.70 | 12.40 | 13.00 | 14.00 | 10.40 | 11.00 | 11.80 |
| Cash Flow per Share 2 | 3.200 | 2.780 | 3.530 | 2.920 | 3.210 | 2.630 | 2.490 | 2.170 |
| Capex 1 | 2,060 | 1,964 | 1,899 | 2,348 | 1,523 | 2,097 | 1,883 | 1,925 |
| Capex / Sales | 8.02% | 7.74% | 7.06% | 8.32% | 6.73% | 8.64% | 7.27% | 7.07% |
| Announcement Date | 11/21/19 | 11/19/20 | 11/18/21 | 11/17/22 | 11/16/23 | - | - | - |
1ZAR in Million2ZAR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
10.36
ZAR
Average target price
18.12
ZAR
Spread / Average Target
+74.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -43.60% | 792M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- LHC Stock
- Financials Life Healthcare Group Holdings Limited
